AUGUST 23, 2022:
UNDATED (AP)- Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring. Vaccinations for babies, toddlers and preschoolers opened in the U.S. in June after months of delay. Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August 2022. Health authorities authorized tot-sized vaccine doses by Pfizer and BioNTech based on a study showing they were safe and produced high levels of virus-fighting antibodies. The new update analyzed COVID-19 diagnoses between March and June 2022 in Pfizer’s ongoing study of the three-dose vaccine.
MAY 23, 2022:
UNDATED (AP)- Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week. It’s the latest step toward letting the littlest kids get the shots. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination. The Food and Drug Administration has begun evaluating data from rival Moderna. That company hopes to offer two kid-sized shots by summer. The FDA has set tentative dates next month for its scientific advisers to publicly debate data from Pfizer and Moderna.
Comments